Aβ (measured by CSF Aβ42/40 or amyloid PET or CSF Aβ42) and tau (evaluated by CSF phosphorylated tau or tau PET) are being refined as the primary mediators of AD-related synaptic loss and eventual neuronal death [4]. The gene discussed is MAPT; the disease is Alzheimer disease.